Topic

New York

A collection of 516 issues

How Long Does It Take to Get Tavalisse Approved by UnitedHealthcare in New York? Complete Timeline & Appeals Guide

Answer Box: Getting Tavalisse Covered by UnitedHealthcare in New York UnitedHealthcare typically processes Tavalisse (fostamatinib) prior authorizations within 24 hours for standard submissions, or within minutes for electronic requests through OptumRx. The fastest path requires your hematologist to submit complete documentation showing failed prior therapies (steroids, IVIG, or TPO agonists)

How to Get Venclexta (venetoclax) Covered by Blue Cross Blue Shield in New York: Complete PA Guide and Appeal Process

Quick Answer: Getting Venclexta Covered in New York Blue Cross Blue Shield of New York requires prior authorization for Venclexta (venetoclax), typically with step therapy requirements for BTK inhibitors like ibrutinib in CLL cases. Three-step path: (1) Your oncologist submits PA via Availity Essentials with diagnosis, TLS monitoring plan, and

How to Get Retevmo (Selpercatinib) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by Blue Cross Blue Shield in New York Retevmo (selpercatinib) requires prior authorization from Blue Cross Blue Shield in New York for RET fusion-positive NSCLC and RET-mutant thyroid cancers. The fastest path to approval: (1) Confirm RET testing with an FDA-approved companion diagnostic, (2) Submit

How to Get Elevidys (delandistrogene moxeparvovec-rokl) Covered by Humana in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Elevidys Covered by Humana in New York Elevidys requires prior authorization from Humana, typically through their Clinical Pharmacy Review (HCPR) process. In New York, you have strong appeal rights including external review through the Department of Financial Services if denied. Start today by: 1) Having your doctor

Myths vs. Facts: Getting Tracleer (bosentan) Covered by Cigna in New York

Answer Box: Getting Tracleer (bosentan) Covered by Cigna in New York Eligibility: WHO Group 1 PAH confirmed by right heart catheterization, prescribed by cardiologist/pulmonologist, enrolled in Tracleer REMS program. Fastest path: Submit prior authorization with RHC results, try generic bosentan first (unless contraindicated), include monthly LFT monitoring plan. First

How Long Does It Take to Get Vyondys 53 (golodirsen) Approved by Blue Cross Blue Shield in New York? Timeline & Appeal Process

Answer Box: Getting Vyondys 53 Approved in New York Getting Vyondys 53 (golodirsen) approved by Blue Cross Blue Shield in New York typically takes 5-14 business days for standard requests, with expedited reviews possible in 24-48 hours for urgent cases. The fastest path requires: (1) genetic testing confirming exon 53

How to Get Pyrukynd (Mitapivat) Covered by Humana in New York: Prior Authorization Guide and Appeal Process

Answer Box: Getting Pyrukynd (Mitapivat) Covered by Humana in New York Pyrukynd (mitapivat) is covered under Humana Medicare Advantage plans as a specialty pharmacy benefit requiring prior authorization. You need genetic confirmation of pyruvate kinase deficiency, prescription from a board-certified hematologist, and clinical severity documentation. If denied, New York residents

How to Get iLink® Corneal Cross-Linking Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting UnitedHealthcare Coverage for iLink® in New York UnitedHealthcare requires prior authorization for iLink® corneal cross-linking in New York. Fastest path to approval: Have your ophthalmologist submit PA through the UnitedHealthcare Provider Portal with serial corneal topography showing ≥1.0 diopter progression over 12-24 months, documented failed conservative

Getting Natpara (Parathyroid Hormone) Coverage from Aetna CVS Health in New York: 2025 Discontinuation Guide and Alternative Options

Answer Box: Natpara Coverage Status in New York Natpara (parathyroid hormone) is no longer available for new prescriptions as Takeda discontinued global manufacturing in December 2024. Aetna CVS Health automatically denies all new Natpara requests regardless of medical necessity. For New York patients: 1) Discuss Yorvipath (FDA-approved August 2024) with

Myths vs. Facts: Getting Vyondys 53 (golodirsen) Covered by UnitedHealthcare in New York

Answer Box: Getting Vyondys 53 Covered by UnitedHealthcare in New York Vyondys 53 (golodirsen) requires prior authorization from UnitedHealthcare and is billed as a medical benefit under J1429. Key requirements: confirmed exon 53-amenable DMD mutation via genetic testing, ambulatory status (6MWT ≥300m), and neuromuscular specialist involvement. If denied, New York